Skip to content
777 Sourcing.

Capability

in-licensing and out-licensing

Suppliers
1
Countries
1

1 in-licensing and out-licensing supplier. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

KINIKSA PHARMACEUTICALS (UK), LTD.

LONDON

Kiniksa Pharmaceuticals is a global biopharmaceutical company founded in 2015 that finds and delivers novel treatments for patients with significant unmet need, with a focus on cardiovascular diseases and immune modulation. Its portfolio includes an FDA-approved therapy and clinical-stage assets, including KPL-387, an investigational monoclonal antibody IL-1 receptor antagonist being evaluated in the Phase 3 PASTORALE trial in recurrent pericarditis.

clinical trialsimmune modulationresearch and development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list in-licensing and out-licensing.

Browse all capabilities